Total Payments
$150,197
2024 Payments
$2,082
Companies
45
Transactions
1,361
Medicare Patients
9,450
Medicare Billing
$2.5M
Payment Breakdown by Category
Other$107,888 (71.8%)
Food & Beverage$25,710 (17.1%)
Consulting$7,010 (4.7%)
Travel$5,054 (3.4%)
Research$4,000 (2.7%)
Education$536.01 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107,888 | 69 | 71.8% |
| Food and Beverage | $25,710 | 1,220 | 17.1% |
| Consulting Fee | $7,010 | 9 | 4.7% |
| Travel and Lodging | $5,054 | 40 | 3.4% |
| Unspecified | $4,000 | 2 | 2.7% |
| Education | $536.01 | 21 | 0.4% |
Payments by Type
General
$146,197
1,359 transactions
Research
$4,000
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $122,382 | 431 | $0 (2024) |
| Janssen Biotech, Inc. | $8,442 | 113 | $0 (2024) |
| Amgen Inc. | $4,746 | 203 | $0 (2024) |
| Daiichi Sankyo Inc. | $4,000 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $1,336 | 63 | $0 (2024) |
| PFIZER INC. | $1,224 | 114 | $0 (2024) |
| GlaxoSmithKline, LLC. | $799.71 | 52 | $0 (2024) |
| Fidia Pharma USA Inc. | $690.86 | 32 | $0 (2024) |
| Radius Health, Inc. | $638.49 | 65 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $594.02 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,082 | 91 | ABBVIE INC. ($656.10) |
| 2023 | $9,626 | 119 | AbbVie Inc. ($7,962) |
| 2022 | $20,081 | 181 | ABBVIE INC. ($15,965) |
| 2021 | $12,509 | 183 | AbbVie Inc. ($9,482) |
| 2020 | $31,574 | 179 | AbbVie Inc. ($26,534) |
| 2019 | $40,705 | 241 | AbbVie, Inc. ($37,661) |
| 2018 | $18,028 | 208 | AbbVie, Inc. ($14,917) |
| 2017 | $15,593 | 159 | AbbVie, Inc. ($9,204) |
All Payment Transactions
1,361 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $66.99 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/15/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $103.96 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Bone Health | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DS5565-A-E309 | Daiichi Sankyo Inc. | $4,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,821 | 25,382 | $1.6M | $416,903 |
| 2022 | 25 | 2,040 | 29,180 | $1.7M | $502,834 |
| 2021 | 30 | 2,806 | 42,570 | $2.6M | $834,628 |
| 2020 | 34 | 2,783 | 36,830 | $2.5M | $748,938 |
Total Patients
9,450
Total Services
133,962
Medicare Billing
$2.5M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 75 | 7,021 | $417,720 | $128,589 | 30.8% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 15 | 10,408 | $468,360 | $110,032 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 552 | $165,600 | $45,508 | 27.5% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 25 | 45 | $88,335 | $25,192 | 28.5% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2023 | 38 | 4,200 | $126,000 | $23,092 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 282 | $59,784 | $16,000 | 26.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 30 | 156 | $49,140 | $13,562 | 27.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 93 | 234 | $34,398 | $11,172 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 66 | $27,786 | $7,718 | 27.8% |
| 73100 | X-ray of wrist, 2 views | Office | 2023 | 82 | 165 | $12,375 | $3,886 | 31.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 172 | 408 | $13,056 | $3,861 | 29.6% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 88 | 178 | $12,282 | $3,841 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $12,870 | $3,686 | 28.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 100 | 100 | $22,700 | $3,302 | 14.5% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 81 | 166 | $10,458 | $3,234 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $8,000 | $2,352 | 29.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 136 | 256 | $6,885 | $2,238 | 32.5% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 32 | 61 | $5,429 | $1,687 | 31.1% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | Office | 2023 | 12 | 15 | $4,350 | $1,676 | 38.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 146 | 196 | $1,960 | $1,630 | 83.2% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 45 | 45 | $3,770 | $1,396 | 37.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,475 | $1,234 | 49.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 20 | 41 | $3,116 | $987.51 | 31.7% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 22 | 22 | $2,464 | $749.07 | 30.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 104 | 671 | $838.75 | $276.57 | 33.0% |
About Dr. David Weiss, MD
Dr. David Weiss, MD is a Rheumatology healthcare provider based in Hattiesburg, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851431159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Weiss, MD has received a total of $150,197 in payments from pharmaceutical and medical device companies, with $2,082 received in 2024. These payments were reported across 1,361 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($107,888).
As a Medicare-enrolled provider, Weiss has provided services to 9,450 Medicare beneficiaries, totaling 133,962 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Hattiesburg, MS
- Active Since 02/07/2007
- Last Updated 09/30/2008
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1851431159
Products in Payments
- RINVOQ (Biological) $30,381
- Rinvoq (Biological) $20,270
- RINVOQ (Drug) $19,744
- Humira (Biological) $14,849
- HUMIRA (Biological) $6,944
- STELARA (Biological) $4,647
- DS-5565 (Drug) $4,000
- Enbrel (Biological) $3,570
- SKYRIZI (Biological) $3,511
- TREMFYA (Drug) $2,636
- XELJANZ (Drug) $1,073
- COSENTYX (Biological) $970.32
- BENLYSTA (Biological) $799.71
- ACTHAR (Biological) $798.46
- PURIFIED CORTROPHIN GEL (Drug) $790.98
- EVENITY (Biological) $669.82
- Tymlos (Biological) $638.49
- SIMPONI ARIA (Biological) $590.71
- DUZALLO (Drug) $567.76
- REMICADE (Biological) $487.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Hattiesburg
Muhammad Ijaz, M.d, M.D
Rheumatology — Payments: $20,761
Rheumatology $20,761
Imad Bitar, Md, MD
Rheumatology — Payments: $19,802
Rheumatology $19,802
Nancy Harrison, M.d, M.D
Rheumatology — Payments: $13,722
Rheumatology $13,722
Portia Harris, Md, MD
Rheumatology — Payments: $4,800
Rheumatology $4,800
Chris Benson, Md, MD
Rheumatology — Payments: $868.55
Rheumatology $868.55